E
Groove Botanicals, Inc. GRVE
$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Groove Botanicals, Inc. (OTC: GRVE) is a publicly traded company that has historically operated in the hemp-derived wellness and cannabidiol (CBD) sector, with activities tied to consumer health products and botanical-based formulations. Public disclosures and OTC market materials indicate that the company has focused on developing and marketing hemp-based consumer products, including tinctures, topical products, and wellness-oriented formulations positioned within the broader nutraceutical and alternative health industries. The company has also explored opportunities connected to cannabis-adjacent consumer markets as regulatory conditions evolved in the United States.

Available public information suggests that Groove Botanicals evolved from earlier corporate structures and business models prior to adopting its current branding and hemp-focused strategy. Historical filings and OTC disclosures indicate periods of restructuring and strategic repositioning common among smaller-cap OTC-listed issuers. Due to limited recent reporting consistency and the absence of extensive audited operational disclosures in widely available public filings, some aspects of the company’s historical development and current operating scale are difficult to independently confirm. Data inconclusive based on available public sources.

Business Operations

Groove Botanicals has historically generated revenue through the sale and distribution of hemp-derived consumer products and related wellness offerings. Public disclosures reference activities associated with branded CBD products, online retail distribution, and product formulation initiatives. The company’s operations appear to have been primarily concentrated in the United States, with a focus on consumer-facing wellness markets rather than large-scale agricultural cultivation or pharmaceutical development. Publicly available information does not clearly identify multiple large-scale operating divisions or separately reported segments comparable to larger publicly traded cannabis or consumer packaged goods companies.

Information available through OTC disclosures and company communications references relationships with formulation, manufacturing, and distribution partners; however, detailed disclosures regarding long-term strategic joint ventures, material subsidiaries, or major controlled production assets remain limited. There is insufficient publicly verified information to conclusively identify significant international operations, proprietary technologies, or major revenue-generating subsidiaries. Data inconclusive based on available public sources.

Strategic Position & Investments

Groove Botanicals’ strategic direction has historically centered on participation in the growing hemp-derived wellness market, particularly products associated with CBD consumer demand in the United States. Company materials and public statements have referenced efforts to expand product offerings, strengthen brand recognition, and position the company within evolving regulatory frameworks governing hemp and cannabis-derived products. Like many micro-cap companies operating in the sector, Groove Botanicals appears to have pursued growth through branding, product commercialization, and market positioning rather than large-scale capital-intensive infrastructure development.

Publicly available information does not provide substantial evidence of major acquisitions, large institutional investments, or extensive ownership stakes in notable portfolio companies. There are also limited verified disclosures regarding significant investments in emerging technologies, biotechnology platforms, or advanced cannabis research initiatives. While the company has been associated with the broader hemp and cannabinoid wellness sector, detailed information regarding material strategic investments or transformative acquisitions could not be independently confirmed through consistently available public filings. Data inconclusive based on available public sources.

Geographic Footprint

Groove Botanicals’ operations and market activity have primarily been associated with the United States, where hemp-derived wellness products experienced regulatory expansion following changes to federal hemp legislation. Public disclosures and OTC market materials do not indicate a substantial multinational operational footprint or significant international manufacturing presence. The company’s commercial focus appears to have been concentrated on U.S.-based consumer markets and domestic distribution channels.

There is limited independently verified information demonstrating material operational influence across Europe, Asia-Pacific, Latin America, or other major international regions. Likewise, publicly available disclosures do not clearly identify foreign subsidiaries, major international partnerships, or cross-border investment platforms. Data inconclusive based on available public sources.

Leadership & Governance

Publicly available disclosures regarding Groove Botanicals’ executive leadership and governance structure have varied over time, reflecting changes commonly seen among smaller OTC-listed companies. Available records indicate management turnover and evolving corporate leadership associated with strategic repositioning efforts. Due to limited recent comprehensive reporting, some executive and governance details could not be consistently verified across multiple current independent sources.

Key executives identified in historical public disclosures include:

  • Howard J. Bucs – Chief Executive Officer
  • Brian Lemasters – Former executive leadership role associated with company operations

Publicly available materials suggest that leadership strategy focused on expanding participation in the hemp-derived wellness market and positioning the company within emerging cannabinoid consumer categories. However, detailed governance philosophies, long-term strategic frameworks, and updated board composition information were not consistently available across recent public disclosures. Data inconclusive based on available public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $230.36
B
AAPL NASDAQ $319.97
B
AVGO NASDAQ $357.90
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $107.14
A
Top Financial Stocks
See All »
B
B
JPM NYSE $358.64
B
V NYSE $375.07
Top Health Care Stocks
See All »
B
LLY NYSE $1,149.36
B
JNJ NYSE $275.23
B
ABBV NYSE $256.46
Top Real Estate Stocks
See All »
B
PLD NYSE $137.34
B
EQIX NASDAQ $1,035.98